CTSC and respiratory system disorder: Additionally, other DPP1 inhibitor candidates including BI 1291583 and HSK31858 have shown favorable clinical prospects in their respective development stages, with these research results further validating the enormous potential of DPP1 inhibition strategies as therapeutic approaches for respiratory diseases (Zhong et al., 2025; Badorrek et al., 2024).